SENSE Theatre for Autism Spectrum Disorder

Waitlist Available
Led By Blythe A Corbett, Ph.D.
Research Sponsored by Vanderbilt University Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Must not have
Be younger than 18 years old
Be older than 65 years old
Screening 3 weeks
Treatment Varies
Follow Uppretest, week 5, week 11, two-month follow-up
Awards & highlights
No Placebo-Only Group

Study Summary

This trial found that the theatre play intervention has the potential to improve social cognition and behavior for adults with autism spectrum disorder.

Eligible Conditions
  • Autism Spectrum Disorder
  • Autism


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pretest, week 5, week 11, two-month follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and pretest, week 5, week 11, two-month follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Contextual Assessment of Social Skills
Change in Incidental Face Memory
Change in Social Responsiveness Scale - Parent (SRS)
+1 more
Secondary outcome measures
Adaptive Behavior Assessment System (ABAS) - Parent-Report
Adaptive Behavior Assessment System (ABAS) - Self-Report
Cambridge Face Memory Test
+5 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: SENSE TheatreExperimental Treatment1 Intervention
A peer-mediated, theatre-based intervention designed to improve social cognition and behavior.
Group II: Waitlist Control GroupActive Control1 Intervention
This group will not receive the intervention during the testing phase of the intervention but will eventually receive the theatre intervention.
First Studied
Drug Approval Stage
How many patients have taken this drug
SENSE Theatre

Find a site

Who is running the clinical trial?

Vanderbilt University Medical CenterLead Sponsor
821 Previous Clinical Trials
656,222 Total Patients Enrolled
15 Trials studying Autism Spectrum Disorder
2,441 Patients Enrolled for Autism Spectrum Disorder
National Institute of Mental Health (NIMH)NIH
2,685 Previous Clinical Trials
1,994,556 Total Patients Enrolled
78 Trials studying Autism Spectrum Disorder
40,876 Patients Enrolled for Autism Spectrum Disorder
Blythe A Corbett, Ph.D.Principal Investigator
Vanderbilt University Medical Center
1 Previous Clinical Trials
136 Total Patients Enrolled
1 Trials studying Autism Spectrum Disorder
136 Patients Enrolled for Autism Spectrum Disorder

Media Library

SENSE Theatre Clinical Trial Eligibility Overview. Trial Name: NCT04349644 — N/A
Autism Spectrum Disorder Research Study Groups: SENSE Theatre, Waitlist Control Group
Autism Spectrum Disorder Clinical Trial 2023: SENSE Theatre Highlights & Side Effects. Trial Name: NCT04349644 — N/A
SENSE Theatre 2023 Treatment Timeline for Medical Study. Trial Name: NCT04349644 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there an age requirement for participation in this investigation?

"As per the stipulated enrolment guidelines, only those aged 18-35 can qualify for this clinical trial."

Answered by AI

What is the principal aim of this research project?

"This trial aims to evaluate changes in Incidental Face Memory over the course of 11 weeks. Secondary outcomes include Cambridge Face Memory Test, Wechsler Memory Scale Face Memory Delay Test, and Wechsler Memory Scale Face Memory Test - all three are standardized measures which assess a participant's ability to remember faces among an array of presented images. An increase in raw score indicates improvement in face memory."

Answered by AI

What qualifications are necessary for participants in this trial to meet?

"This medical study is looking for 40 individuals aged 18 to 35 with a diagnosis of Autism Spectrum Disorder (DSM-V criteria) confirmed by the Autism Diagnostic Observation Schedule. Furthermore, only participants without educational opportunities and those with an IQ greater than 70 shall be eligible for enrollment."

Answered by AI

Are there currently openings available in this medical experiment?

"Precisely. According to, the trial has been recruiting since October 21st 2020 and was most recently updated on February 17th 2022. The study is looking for 40 individuals from 1 particular site."

Answered by AI

What is the scope of participants in this clinical exploration?

"Affirmative. According to the data found on, this trial is actively recruiting participants and was first posted on October 21st 2020. 40 individuals need to be sourced from 1 location in order for the study to move forward."

Answered by AI

Who else is applying?

What state do they live in?
New York
How old are they?
18 - 65
What portion of applicants met pre-screening criteria?
Did not meet criteria
~9 spots leftby Mar 2024